This is about what one could expect from an limited article about Med-T’s new technology as explained to an audience that knows next to nothing about diabetes and insulin pump technology, much less explaining anything about an algorithm. We’ve all watched as eyes glaze over at the first mention of basal, bolus, or autoimmune in any casual interest in things diabetes.
I think it also reflects the limited attention span of most general audiences. This article was written in very broad brush-strokes with little to no detail. It’s unfortunate that this is the type of article that much of the “media” has been reduced to. Headlines are written with click-bait in mind instead of a real preview of the meat of the story.
The uninformed public take in the mind of the public is that insulin pumps solve diabetes. Isn’t that wonderful? I remember in 1987, when I got my MM504 pump and people thought then that the pump could sense blood sugar and deliver the right amount of insulin.
This superficial attention span of the average member of the public when it comes to disease that does not affect them directly is a simple reality that is not going away any time soon. We’re all ignorant of many diseases that don’t impact our lives. We all allocate our personal bandwidth using a variety of values.